Careers  |  Media  |  Contact us

NIPT (Basic)

Test Name

NIPT (Basic)

Lab Visit

Test Code

GEN0293

Test Components/ Genes/ Parameters

Sample Report

Click on Icon

Test Information

TAT DETAILS

8-10 days

PRE-TEST INSTRUCTIONS

This test can be taken by patients who: – Are more than 10 weeks pregnant – for singleton or twin pregnancy – Have conceived via IVF

CLINICAL UTILITY

Screening test for the most common fetal aneuploidy disorders (trisomy 13, trisomy 18, trisomy 21 [Down syndrome], Turner syndrome, sex chromosome aneuploidies [XXX, XXY, XYY]).

SPECIMEN STABILITY

NA

METHODOLOGY

Next Generation Sequencing

STORAGE TEMPERATURE

NA

SPECIMEN TYPE

10 ml Maternal Blood in Strek Tube

Frequently Asked Questions

Non Invasive Prenatal Screening Test (NIPT) Basic
It analyses the cell free fetal DNA present in the maternal blood for the presence of chromosomal aneuploidies
The expectant mother’s blood is drawn and sent to the laboratory for testing. It is important to send the latest sonography reports, clinical history
The test can be done anytime after 10 week pregnancy.
The expectant mother’s blood is drawn and sent to the laboratory for testing.
No Risk
The report will indicate the probability of a baby being born with the screened chromosomal conditions. Results are provided as scores that is compared to normal and below normal ranges. The probability of risk is given as: – Low risk: The pregnancy is unlikely to be affected by aneuploidies that were screened. – High risk: The pregnancy is likely to be affected by trisomy or aneuploidy. Further confirmatory tests will be required. – No result: May occcur due to insufficient (less than 3.5% fetal fraction) placental DNA in the sample. In the event of a positive test result, your healthcare provider will discuss further diagnostic options for a definitive diagnosis such as: – High-resolution ultrasound – Chorionic villus sampling (CVS) – Amniocentesis